Peregrine Pharmaceuticals shares owned by Tower Research Capital
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $157k | 13k | 12.35 |
| 2024-09-30 | $84k | 7.4k | 11.38 |
| 2024-06-30 | $86k | 12k | 7.14 |
| 2024-03-31 | $12k | 1.8k | 6.70 |
| 2023-09-30 | $32k | 3.4k | 9.44 |
| 2023-06-30 | $85k | 6.1k | 13.97 |
| 2023-03-31 | $52k | 2.8k | 18.59 |
| 2022-12-31 | $0 | 5.1k | 0.00 |
| 2022-09-30 | $72k | 3.8k | 19.06 |
| 2022-06-30 | $189k | 12k | 15.26 |
| 2022-03-31 | $33k | 1.7k | 19.91 |
| 2021-12-31 | $191k | 6.6k | 28.84 |
| 2021-09-30 | $255k | 12k | 21.59 |
| 2021-06-30 | $62k | 2.4k | 25.66 |
| 2021-03-31 | $90k | 4.9k | 18.33 |
| 2020-12-31 | $80k | 8.0k | 10.00 |
| 2020-09-30 | $682k | 61k | 11.24 |
| 2020-06-30 | $61k | 12k | 5.00 |
| 2019-09-30 | $36k | 5.3k | 6.80 |
| 2019-06-30 | $32k | 5.4k | 5.89 |
| 2019-03-31 | $88k | 21k | 4.25 |
| 2018-12-31 | $4.0k | 887 | 4.51 |